Kairos Pharma (KAPA) Shares Outstanding (2024 - 2025)
Historic Shares Outstanding for Kairos Pharma (KAPA) over the last 2 years, with Q2 2025 value amounting to $17.7 million.
- Kairos Pharma's Shares Outstanding rose 6798.61% to $17.7 million in Q2 2025 from the same period last year, while for Jun 2025 it was $17.7 million, marking a year-over-year increase of 6798.61%. This contributed to the annual value of $13.7 million for FY2024, which is N/A changed from last year.
- As of Q2 2025, Kairos Pharma's Shares Outstanding stood at $17.7 million, which was up 6798.61% from $16.4 million recorded in Q1 2025.
- Kairos Pharma's 5-year Shares Outstanding high stood at $17.7 million for Q2 2025, and its period low was $10.6 million during Q1 2024.